The broader implementation of step therapy in Medicare Advantage could significantly influence the treatment access and experience as well as health outcomes for millions of patients with diverse health profiles.
Related Posts
What to watch for concerning drug pricing and market access in 2026 – Healthcare Economist
That is the topic of an Evidence Base article out today titled “Reflecting on 2025, looking to 2026: Experts outline […]
America’s Real ‘Secretary of War’
This article was featured in the One Story to Read Today newsletter. Sign up for it here. Three days into 2026, the United States military […]
Idiopathic Pulmonary Fibrosis (IPF) | Symptoms & Treatment
Idiopathic pulmonary fibrosis, a relatively rare name a few years back, has seen a significant jump in cases in the past few years, mainly the […]